- Home
- ATNM vs PVL Comparison
ATNM vs PVL Comparison
Compare ATNM & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- PVL
- Stock Information
- Founded
- ATNM 2000
- PVL 2011
- Country
- ATNM United States
- PVL United States
- Employees
- ATNM N/A
- PVL N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- PVL Oil & Gas Production
- Sector
- ATNM Health Care
- PVL Energy
- Exchange
- ATNM Nasdaq
- PVL Nasdaq
- Market Cap
- ATNM 56.5M
- PVL 51.1M
- IPO Year
- ATNM N/A
- PVL N/A
- Fundamental
- Price
- ATNM $1.51
- PVL $1.55
- Analyst Decision
- ATNM Strong Buy
- PVL
- Analyst Count
- ATNM 5
- PVL 0
- Target Price
- ATNM $14.20
- PVL N/A
- AVG Volume (30 Days)
- ATNM 245.6K
- PVL 45.8K
- Earning Date
- ATNM 11-26-2024
- PVL 01-01-0001
- Dividend Yield
- ATNM N/A
- PVL 11.61%
- EPS Growth
- ATNM N/A
- PVL N/A
- EPS
- ATNM N/A
- PVL 0.20
- Revenue
- ATNM $81,000.00
- PVL $2,897,081.00
- Revenue This Year
- ATNM $186.10
- PVL N/A
- Revenue Next Year
- ATNM $19,248.94
- PVL N/A
- P/E Ratio
- ATNM N/A
- PVL $7.65
- Revenue Growth
- ATNM 80.00
- PVL N/A
- 52 Week Low
- ATNM $1.33
- PVL $1.03
- 52 Week High
- ATNM $10.24
- PVL $2.20
- Technical
- Relative Strength Index (RSI)
- ATNM 36.23
- PVL 45.27
- Support Level
- ATNM $1.82
- PVL $1.51
- Resistance Level
- ATNM $1.97
- PVL $1.61
- Average True Range (ATR)
- ATNM 0.12
- PVL 0.05
- MACD
- ATNM -0.02
- PVL -0.00
- Stochastic Oscillator
- ATNM 11.52
- PVL 26.31
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production the sale of oil and natural gas production from primarily non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.